VIVO logo

Meridian Bioscience (VIVO) EBITDA

Annual EBITDA

$72.02 M
-$35.60 M-33.08%

September 30, 2022

Summary

Performance

1-Year Change

-33.08%

3-Year Change

+65.69%

5-Year Change

+55.92%

15-Year Change

+55.92%

VIVO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$107.61 M
VIVO annual EBITDA is currently -33.08% below its historical high of $107.61 million

3-Year Low

$72.02 M
VIVO annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2022
VIVO previous annual earnings announcement was published on Sep 30, 2022

Next Annual Earnings Report Date

N/A
VIVO next annual earnings announcement has not yet been scheduled

OtherVIVOprofitabilitymetrics:

Annual Revenue

$333.02 M
VIVO annual revenue is $333.02 million

Annual Net Income

$42.46 M
VIVO annual net profit is $42.46 million

Annual EBIT

$55.51 M
VIVO annual earnings before interest & taxes is $55.51 million

Annual EPS

$0.96
VIVO annual earnings per share is $0.96

Quarterly EBITDA

$8.92 M
+$11.16 M+498.48%

September 30, 2022

Summary

Performance

3-Month Change

+498.48%

1-Year Change

-27.98%

3-Year Change

-4.53%

5-Year Change

-19.32%

VIVO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$41.03 M
VIVO quarterly EBITDA is currently -78.25% below its historical high of $41.03 million

3-Year Low

-$2.24 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVO next earnings announcement has not yet been scheduled

OtherVIVOprofitabilitymetrics:

Quarterly Revenue

$65.67 M
VIVO quarterly revenue is $65.67 million

Quarterly Net Income

$5.71 M
VIVO quarterly net profit is $5.71 million

Quarterly EBIT

$4.85 M
VIVO quarterly earnings before interest & taxes is $4.85 million

Quarterly EPS

$0.13
VIVO quarterly earnings per share is $0.13

TTM EBITDA

$72.02 M
-$3.47 M-4.59%

September 30, 2022

Summary

Performance

3-Month Change

-4.59%

1-Year Change

-33.08%

3-Year Change

+88.14%

5-Year Change

+88.14%

VIVO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$127.37 M
VIVO TTM EBITDA is currently -43.46% below its historical high of $127.37 million

3-Year Low

$72.02 M
VIVO TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVO next earnings announcement has not yet been scheduled

OtherVIVOprofitabilitymetrics:

TTM Revenue

$333.02 M
VIVO TTM revenue is $333.02 million

TTM Net Income

$42.46 M
VIVO TTM net profit is $42.46 million

TTM EBIT

$55.51 M
VIVO TTM earnings before interest & taxes is $55.51 million

TTM EPS

$0.96
VIVO TTM earnings per share is $0.96

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$72.02 M
VIVO annual EBITDA is $72.02 million

Annual Net Income

$42.46 M
VIVO annual net profit is $42.46 million

Annual Interest Expense

$1.19 M
VIVO annual interest expense is $1.19 million

Annual Income Tax

$11.86 M
VIVO annual income tax is $11.86 million

Annual D&A

$16.51 M
VIVO annual depreciation & amortization is $16.51 million

VIVO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-33.1%-28.0%-33.1%
3 y3 years+65.7%-4.5%+88.1%
5 y5 years+55.9%-19.3%+88.1%

VIVO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-33.1%at low-78.3%-125.1%-25.9%at low
5 y5-year-33.1%-39.6%-78.3%-125.1%-43.5%-46.8%
alltimeall time-33.1%-102.0%-78.3%-147.1%-43.5%-101.4%

Meridian Bioscience EBITDA History

DateAnnualQuarterlyTTM
Sep 2022
$72.02 M(-33.1%)
$8.92 M(-498.5%)
$72.02 M(-4.6%)
Jun 2022
-
-$2.24 M(-105.5%)
$75.48 M(-22.3%)
Mar 2022
-
$41.03 M(+68.8%)
$97.21 M(+4.1%)
Dec 2021
-
$24.31 M(+96.2%)
$93.41 M(-13.2%)
Sep 2021
$107.61 M(+42.6%)
$12.39 M(-36.4%)
$107.61 M(-0.2%)
Jun 2021
-
$19.49 M(-47.7%)
$107.81 M(-15.4%)
Mar 2021
-
$37.23 M(-3.3%)
$127.37 M(+19.9%)
Dec 2020
-
$38.51 M(+206.2%)
$106.27 M(+40.8%)
Sep 2020
$75.49 M(+73.7%)
$12.58 M(-67.8%)
$75.49 M(+4.5%)
Jun 2020
-
$39.05 M(+142.2%)
$72.26 M(+69.3%)
Mar 2020
-
$16.13 M(+108.5%)
$42.67 M(+11.5%)
Dec 2019
-
$7.73 M(-17.2%)
$38.28 M(-11.9%)
Sep 2019
$43.47 M(+9.1%)
$9.35 M(-1.3%)
$43.47 M(+0.5%)
Jun 2019
-
$9.47 M(-19.3%)
$43.24 M(-3.3%)
Mar 2019
-
$11.73 M(-9.2%)
$44.70 M(+4.9%)
Dec 2018
-
$12.92 M(+41.7%)
$42.61 M(+7.0%)
Sep 2018
$39.82 M(-13.8%)
$9.12 M(-16.5%)
$39.82 M(-4.6%)
Jun 2018
-
$10.93 M(+13.4%)
$41.76 M(+12.2%)
Mar 2018
-
$9.64 M(-4.9%)
$37.23 M(-15.8%)
Dec 2017
-
$10.14 M(-8.3%)
$44.20 M(-4.3%)
Sep 2017
$46.19 M(-20.6%)
$11.06 M(+73.0%)
$46.19 M(-0.1%)
Jun 2017
-
$6.39 M(-61.5%)
$46.23 M(-17.2%)
Mar 2017
-
$16.61 M(+37.0%)
$55.83 M(+0.9%)
Dec 2016
-
$12.13 M(+9.3%)
$55.31 M(-4.9%)
Sep 2016
$58.17 M(-3.5%)
$11.10 M(-30.6%)
$58.17 M(-5.5%)
Jun 2016
-
$15.99 M(-0.7%)
$61.53 M(+0.9%)
Mar 2016
-
$16.10 M(+7.4%)
$61.01 M(-1.2%)
Dec 2015
-
$14.98 M(+3.6%)
$61.77 M(+1.5%)
Sep 2015
$60.28 M(+4.5%)
$14.46 M(-6.5%)
$60.86 M(+2.4%)
Jun 2015
-
$15.47 M(-8.3%)
$59.46 M(+1.6%)
Mar 2015
-
$16.86 M(+19.9%)
$58.51 M(-0.3%)
Dec 2014
-
$14.06 M(+7.7%)
$58.70 M(+1.8%)
Sep 2014
$57.67 M(-8.4%)
$13.06 M(-10.0%)
$57.67 M(-2.7%)
Jun 2014
-
$14.52 M(-14.9%)
$59.26 M(-4.2%)
Mar 2014
-
$17.05 M(+30.8%)
$61.85 M(+0.6%)
Dec 2013
-
$13.04 M(-11.0%)
$61.49 M(-2.3%)
Sep 2013
$62.94 M(+12.5%)
$14.66 M(-14.3%)
$62.94 M(+2.0%)
Jun 2013
-
$17.11 M(+2.5%)
$61.72 M(+4.5%)
Mar 2013
-
$16.69 M(+15.2%)
$59.04 M(+0.4%)
Dec 2012
-
$14.49 M(+7.8%)
$58.78 M(+5.0%)
Sep 2012
$55.96 M(+17.8%)
$13.44 M(-6.8%)
$55.96 M(+0.8%)
Jun 2012
-
$14.42 M(-12.2%)
$55.54 M(+5.5%)
Mar 2012
-
$16.43 M(+40.8%)
$52.66 M(+8.2%)
Dec 2011
-
$11.67 M(-10.3%)
$48.66 M(+2.4%)
Sep 2011
$47.52 M(+1.0%)
$13.02 M(+12.8%)
$47.52 M(+6.0%)
Jun 2011
-
$11.54 M(-7.2%)
$44.85 M(-0.1%)
Mar 2011
-
$12.43 M(+18.1%)
$44.88 M(+5.2%)
Dec 2010
-
$10.53 M(+1.8%)
$42.68 M(-9.3%)
Sep 2010
$47.06 M(-11.4%)
$10.35 M(-10.6%)
$47.06 M(-7.3%)
Jun 2010
-
$11.57 M(+13.1%)
$50.80 M(-3.9%)
Mar 2010
-
$10.23 M(-31.4%)
$52.85 M(-3.5%)
Dec 2009
-
$14.91 M(+5.9%)
$54.76 M(+3.0%)
Sep 2009
$53.14 M(+8.8%)
$14.08 M(+3.3%)
$53.14 M(+3.0%)
Jun 2009
-
$13.63 M(+12.3%)
$51.60 M(+3.1%)
Mar 2009
-
$12.14 M(-8.7%)
$50.03 M(+0.5%)
Dec 2008
-
$13.29 M(+6.0%)
$49.79 M(+2.0%)
Sep 2008
$48.82 M(+23.8%)
$12.54 M(+4.0%)
$48.82 M(+6.1%)
Jun 2008
-
$12.06 M(+1.5%)
$46.02 M(+3.3%)
Mar 2008
-
$11.89 M(-3.5%)
$44.55 M(+4.6%)
Dec 2007
-
$12.32 M(+26.5%)
$42.59 M(+8.1%)
Sep 2007
$39.43 M(+22.5%)
$9.74 M(-8.0%)
$39.41 M(+2.3%)
Jun 2007
-
$10.59 M(+6.7%)
$38.51 M(+7.4%)
Mar 2007
-
$9.93 M(+8.5%)
$35.86 M(+5.3%)
Dec 2006
-
$9.15 M(+3.5%)
$34.05 M(+5.8%)
Sep 2006
$32.18 M(+30.9%)
$8.84 M(+11.3%)
$32.18 M(+5.8%)
Jun 2006
-
$7.94 M(-2.3%)
$30.43 M(+3.9%)
Mar 2006
-
$8.12 M(+11.6%)
$29.29 M(+6.9%)
Dec 2005
-
$7.28 M(+2.8%)
$27.41 M(+11.5%)
Sep 2005
$24.58 M(+31.2%)
$7.08 M(+4.2%)
$24.58 M(+8.6%)
Jun 2005
-
$6.80 M(+8.9%)
$22.63 M(+12.2%)
Mar 2005
-
$6.24 M(+40.3%)
$20.18 M(+5.9%)
Dec 2004
-
$4.45 M(-13.4%)
$19.05 M(+1.7%)
Sep 2004
$18.73 M(+13.1%)
$5.14 M(+18.3%)
$18.73 M(+5.6%)
Jun 2004
-
$4.34 M(-15.1%)
$17.74 M(+1.7%)
Mar 2004
-
$5.12 M(+23.9%)
$17.44 M(+2.5%)
Dec 2003
-
$4.13 M(-0.3%)
$17.02 M(+2.7%)
DateAnnualQuarterlyTTM
Sep 2003
$16.57 M(+20.8%)
$4.14 M(+2.3%)
$16.57 M(+8.2%)
Jun 2003
-
$4.05 M(-13.9%)
$15.32 M(+1.2%)
Mar 2003
-
$4.70 M(+27.7%)
$15.13 M(+6.9%)
Dec 2002
-
$3.68 M(+27.3%)
$14.16 M(+3.2%)
Sep 2002
$13.71 M(-1045.1%)
$2.89 M(-25.1%)
$13.71 M(-17.3%)
Jun 2002
-
$3.86 M(+3.5%)
$16.58 M(+7.9%)
Mar 2002
-
$3.73 M(+15.2%)
$15.36 M(+32.5%)
Dec 2001
-
$3.23 M(-43.8%)
$11.59 M(+49.9%)
Sep 2001
-$1.45 M(-109.7%)
$5.75 M(+117.8%)
$7.73 M(+109.2%)
Jun 2001
-
$2.64 M(-6390.5%)
$3.70 M(-33.8%)
Mar 2001
-
-$42.00 K(-93.2%)
$5.58 M(-44.4%)
Dec 2000
-
-$621.00 K(-136.1%)
$10.04 M(-32.9%)
Sep 2000
$14.96 M(-12.6%)
$1.72 M(-62.1%)
$14.96 M(-19.1%)
Jun 2000
-
$4.53 M(+2.6%)
$18.49 M(-0.2%)
Mar 2000
-
$4.42 M(+2.7%)
$18.52 M(+0.3%)
Dec 1999
-
$4.30 M(-18.0%)
$18.46 M(+7.6%)
Sep 1999
$17.11 M(+51.5%)
$5.25 M(+15.0%)
$17.16 M(+23.3%)
Jun 1999
-
$4.56 M(+4.8%)
$13.92 M(+11.7%)
Mar 1999
-
$4.35 M(+45.1%)
$12.45 M(+7.4%)
Dec 1998
-
$3.00 M(+50.0%)
$11.60 M(+4.5%)
Sep 1998
$11.30 M(-12.4%)
$2.00 M(-35.5%)
$11.10 M(-16.5%)
Jun 1998
-
$3.10 M(-11.4%)
$13.30 M(-2.9%)
Mar 1998
-
$3.50 M(+40.0%)
$13.70 M(+6.2%)
Dec 1997
-
$2.50 M(-40.5%)
$12.90 M(0.0%)
Sep 1997
$12.90 M(+20.6%)
$4.20 M(+20.0%)
$12.90 M(+4.0%)
Jun 1997
-
$3.50 M(+29.6%)
$12.40 M(+6.0%)
Mar 1997
-
$2.70 M(+8.0%)
$11.70 M(+0.9%)
Dec 1996
-
$2.50 M(-32.4%)
$11.60 M(+8.4%)
Sep 1996
$10.70 M(+24.4%)
$3.70 M(+32.1%)
$10.70 M(+10.3%)
Jun 1996
-
$2.80 M(+7.7%)
$9.70 M(+5.4%)
Mar 1996
-
$2.60 M(+62.5%)
$9.20 M(+3.4%)
Dec 1995
-
$1.60 M(-40.7%)
$8.90 M(+3.5%)
Sep 1995
$8.60 M(+30.3%)
$2.70 M(+17.4%)
$8.60 M(+3.6%)
Jun 1995
-
$2.30 M(0.0%)
$8.30 M(+7.8%)
Mar 1995
-
$2.30 M(+76.9%)
$7.70 M(+6.9%)
Dec 1994
-
$1.30 M(-45.8%)
$7.20 M(+7.5%)
Sep 1994
$6.60 M(+40.4%)
$2.40 M(+41.2%)
$6.70 M(+9.8%)
Jun 1994
-
$1.70 M(-5.6%)
$6.10 M(+7.0%)
Mar 1994
-
$1.80 M(+125.0%)
$5.70 M(+14.0%)
Dec 1993
-
$800.00 K(-55.6%)
$5.00 M(+6.4%)
Sep 1993
$4.70 M(+46.9%)
$1.80 M(+38.5%)
$4.70 M(+27.0%)
Jun 1993
-
$1.30 M(+18.2%)
$3.70 M(+8.8%)
Mar 1993
-
$1.10 M(+120.0%)
$3.40 M(+9.7%)
Dec 1992
-
$500.00 K(-37.5%)
$3.10 M(-6.1%)
Sep 1992
$3.20 M(+88.2%)
$800.00 K(-20.0%)
$3.30 M(+13.8%)
Jun 1992
-
$1.00 M(+25.0%)
$2.90 M(+16.0%)
Mar 1992
-
$800.00 K(+14.3%)
$2.50 M(+13.6%)
Dec 1991
-
$700.00 K(+75.0%)
$2.20 M(+15.8%)
Sep 1991
$1.70 M(+41.7%)
$400.00 K(-33.3%)
$1.90 M(0.0%)
Jun 1991
-
$600.00 K(+20.0%)
$1.90 M(+11.8%)
Mar 1991
-
$500.00 K(+25.0%)
$1.70 M(+6.3%)
Dec 1990
-
$400.00 K(0.0%)
$1.60 M(+14.3%)
Sep 1990
$1.20 M(+100.0%)
$400.00 K(0.0%)
$1.40 M(+55.6%)
Jun 1990
-
$400.00 K(0.0%)
$900.00 K(+28.6%)
Mar 1990
-
$400.00 K(+100.0%)
$700.00 K(-61.1%)
Dec 1989
-
$200.00 K(-300.0%)
$1.80 M(-41.9%)
Sep 1989
$600.00 K(+100.0%)
-$100.00 K(-150.0%)
$3.10 M(-410.0%)
Jun 1989
-
$200.00 K(-86.7%)
-$1.00 M(-600.0%)
Mar 1989
-
$1.50 M(0.0%)
$200.00 K(-300.0%)
Dec 1988
-
$1.50 M(-135.7%)
-$100.00 K(0.0%)
Sep 1988
$300.00 K(-40.0%)
-$4.20 M(-400.0%)
-$100.00 K(-120.0%)
Jun 1988
-
$1.40 M(+16.7%)
$500.00 K(+66.7%)
Mar 1988
-
$1.20 M(-20.0%)
$300.00 K(-40.0%)
Dec 1987
-
$1.50 M(-141.7%)
$500.00 K(+150.0%)
Sep 1987
$500.00 K(-80.8%)
-$3.60 M(-400.0%)
$200.00 K(-85.7%)
Jun 1987
-
$1.20 M(-14.3%)
$1.40 M(-17.6%)
Mar 1987
-
$1.40 M(+16.7%)
$1.70 M(-15.0%)
Dec 1986
-
$1.20 M(-150.0%)
$2.00 M(-20.0%)
Sep 1986
$2.60 M(+36.8%)
-$2.40 M(-260.0%)
$2.50 M(-16.7%)
Jun 1986
-
$1.50 M(-11.8%)
$3.00 M(+11.1%)
Mar 1986
-
$1.70 M(0.0%)
$2.70 M(+22.7%)
Dec 1985
-
$1.70 M(-189.5%)
$2.20 M(+29.4%)
Sep 1985
$1.90 M
-$1.90 M(-258.3%)
$1.70 M(-52.8%)
Jun 1985
-
$1.20 M(0.0%)
$3.60 M(+50.0%)
Mar 1985
-
$1.20 M(0.0%)
$2.40 M(+100.0%)
Dec 1984
-
$1.20 M
$1.20 M

FAQ

  • What is Meridian Bioscience annual EBITDA?
  • What is the all time high annual EBITDA for Meridian Bioscience?
  • What is Meridian Bioscience annual EBITDA year-on-year change?
  • What is Meridian Bioscience quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Meridian Bioscience?
  • What is Meridian Bioscience quarterly EBITDA year-on-year change?
  • What is Meridian Bioscience TTM EBITDA?
  • What is the all time high TTM EBITDA for Meridian Bioscience?
  • What is Meridian Bioscience TTM EBITDA year-on-year change?

What is Meridian Bioscience annual EBITDA?

The current annual EBITDA of VIVO is $72.02 M

What is the all time high annual EBITDA for Meridian Bioscience?

Meridian Bioscience all-time high annual EBITDA is $107.61 M

What is Meridian Bioscience annual EBITDA year-on-year change?

Over the past year, VIVO annual EBITDA has changed by -$35.60 M (-33.08%)

What is Meridian Bioscience quarterly EBITDA?

The current quarterly EBITDA of VIVO is $8.92 M

What is the all time high quarterly EBITDA for Meridian Bioscience?

Meridian Bioscience all-time high quarterly EBITDA is $41.03 M

What is Meridian Bioscience quarterly EBITDA year-on-year change?

Over the past year, VIVO quarterly EBITDA has changed by -$3.47 M (-27.98%)

What is Meridian Bioscience TTM EBITDA?

The current TTM EBITDA of VIVO is $72.02 M

What is the all time high TTM EBITDA for Meridian Bioscience?

Meridian Bioscience all-time high TTM EBITDA is $127.37 M

What is Meridian Bioscience TTM EBITDA year-on-year change?

Over the past year, VIVO TTM EBITDA has changed by -$35.60 M (-33.08%)